Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2025.06.17

Peptide research center

Sai Life Sciences’ Peptide Research Center gets featured in Lab Design News

Sai Life Sciences’ newly launched Peptide Research Center was featured in Lab Design News, offering insights into the design philosophy and intent behind the facility.

The article showcases how the center brings together synthesis, purification, and conjugation under one roof, with a layout optimized for high-throughput workflows and seamless cross-functional collaboration.

The feature also spotlighted the facility’s emphasis on sustainability—incorporating energy-efficient systems, advanced air handling, and reusable materials to reduce environmental impact. These elements are aligned with Sai Life Sciences’ broader commitment to responsible operations and green chemistry principles.

The Peptide Research Center is part of Sai Life Sciences’ broader strategy to strengthen its discovery offerings. With growing interest in peptide-based therapeutics, the facility adds both scale and sophistication to the company’s capabilities, offering clients an integrated and future-ready solution for complex peptide programs.

Read the full interview here: The Structural Foundation of a Growing Peptide Research Hub — Lab Design News

Share article

More News

2026.05.16

Sai Life Sciences grows topline by 29% & doubles net profit in FY26

EBITDA up by 56%YoY; Net Profit up by 109%YoY Hyderabad, May 14, 2026: Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), one of India’s fastest growing Contract Research, Development and Manufacturing Organizations (CRDMO) announced its financial results for the fourth quarter and full year ended 31 March 2026. Commenting on the performance during the […]
Read more

2026.05.11

Sai Life Sciences becomes first Indian CRDMO with a site powered by 100% renewable energy

Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India’s leading integrated contract research, development, and manufacturing organizations (CRDMOs), today announced that its Bidar campus — comprising Unit IV, the company’s flagship API manufacturing facility, and Unit VI, its animal health API manufacturing facility — now operates entirely on renewable power. With this […]
Read more

2026.04.06

Sai Life Sciences recognized as Best Organization for Women (BOW) 2026 by ET Edge

Sai Life Sciences has been recognized as a Best Organization for Women (BOW) 2026 by ET Edge, reinforcing its continued commitment to fostering an inclusive, supportive, and empowering workplace for women. This recognition reflects the organization’s sustained efforts to build an environment where women can thrive—both professionally and personally. At Sai, these efforts are anchored […]
Read more

2026.03.27

Inside Sai Life Sciences’ Integrated R&D Campus: Accelerating Drug Development

In a recent feature published in R&D World, Sai Life Sciences’ Integrated R&D Campus in Hyderabad is showcased as a model for accelerating drug discovery and development through true scientific integration.In the article, Dr. B.V.N.B.S. Sarma, Senior Vice President – Discovery, highlights how co-locating multidisciplinary teams—from medicinal chemistry and biology to DMPK, developability, process development, […]
Read more

2026.03.27

Sai Life Sciences hosts Biotech Pitch Day 2026 at Boston Site

Sai Life Sciences successfully hosted its Biotech Pitch Day 2026 at its Boston-area site on March 19, bringing together a dynamic group of emerging biotech innovators, scientific leaders, and industry experts. The event was designed as a platform for early-stage biotech companies to showcase their science, strengthen visibility, and engage with potential collaborators across the […]
Read more